FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092483516> ?p ?o ?g. }

• W3092483516 endingPage "140" @default.
• W3092483516 startingPage "134" @default.
• W3092483516 abstract "Unsuccessful cytogenetic (US) analysis at baseline has been reported to be a poor prognostic feature in patients with acute myeloid leukemia (AML). We conducted this study to examine the prognostic impact of UC/inconclusive cytogenetic analysis on outcomes in patients with AML undergoing allogeneic hematopoietic stem cell transplantation (Allo HSCT). We retrospectively analyzed all adults undergoing Allo HSCT for AML from January 2011 to August 2019. Patients with any documented cytogenetic abnormalities were excluded. Baseline characteristics and transplant outcomes were compared between patients with normal cytogenetics and those with UC. Overall, 243 AML patients (median age, 55 years; 55.1% female) were included. UC were reported in 79 patients, whereas 164 patients had a normal karyotype. The two groups were similar to each other in terms of baseline demographics, treatment received, and transplant related variables. There was no difference between patients with UC and normal cytogenetics in terms of relapse-free survival (66 months vs. 42 months, p = .53) or overall survival (OS; 77 months vs. 76 months, p = .72). Survival parameters remained similar even in subgroup analysis based on NPM1 and FLT3 mutation status. Significant predictors of OS after Allo HSCT in AML patients with UC were increased age at time of Allo HSCT (hazard ratio [HR] = –1.049; 95% confidence interval [CI], 1.005–1.095), favorable (NPM1Mut/FLT3wt) mutation profile (HR = 0.11; 95% CI, 0.01–0.84), neutrophil engraftment < 17 days, and absence of chronic graft-versus-host disease (HR = 3.27; 95% CI, 1.20–8.60). Outcomes after Allo HSCT are comparable between AML patients with UC analysis and patients with normal cytogenetics even after stratification based on molecular risk factors. Allogeneic Allo HSCT may mitigate the poor prognosis of UC analysis in patients with AML." @default.
• W3092483516 created "2020-10-15" @default.
• W3092483516 creator A5003519204 @default.
• W3092483516 creator A5014346242 @default.
• W3092483516 creator A5015894671 @default.
• W3092483516 creator A5017586094 @default.
• W3092483516 creator A5038048073 @default.
• W3092483516 creator A5040159118 @default.
• W3092483516 creator A5049287768 @default.
• W3092483516 creator A5051261755 @default.
• W3092483516 creator A5071646305 @default.
• W3092483516 creator A5072952978 @default.
• W3092483516 creator A5073179735 @default.
• W3092483516 creator A5080055664 @default.
• W3092483516 creator A5084708084 @default.
• W3092483516 date "2021-06-01" @default.
• W3092483516 modified "2023-10-18" @default.
• W3092483516 title "Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation" @default.
• W3092483516 cites W1492609361 @default.
• W3092483516 cites W1534965621 @default.
• W3092483516 cites W1965240031 @default.
• W3092483516 cites W1974784314 @default.
• W3092483516 cites W2023708667 @default.
• W3092483516 cites W2035603803 @default.
• W3092483516 cites W2137807402 @default.
• W3092483516 cites W2144395887 @default.
• W3092483516 cites W2271160032 @default.
• W3092483516 cites W2559537906 @default.
• W3092483516 cites W2581670216 @default.
• W3092483516 cites W2913254252 @default.
• W3092483516 cites W2913815177 @default.
• W3092483516 cites W2998721977 @default.
• W3092483516 doi "https://doi.org/10.1016/j.hemonc.2020.09.001" @default.
• W3092483516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33049225" @default.
• W3092483516 hasPublicationYear "2021" @default.
• W3092483516 type Work @default.
• W3092483516 sameAs 3092483516 @default.
• W3092483516 citedByCount "1" @default.
• W3092483516 countsByYear W30924835162023 @default.
• W3092483516 crossrefType "journal-article" @default.
• W3092483516 hasAuthorship W3092483516A5003519204 @default.
• W3092483516 hasAuthorship W3092483516A5014346242 @default.
• W3092483516 hasAuthorship W3092483516A5015894671 @default.
• W3092483516 hasAuthorship W3092483516A5017586094 @default.
• W3092483516 hasAuthorship W3092483516A5038048073 @default.
• W3092483516 hasAuthorship W3092483516A5040159118 @default.
• W3092483516 hasAuthorship W3092483516A5049287768 @default.
• W3092483516 hasAuthorship W3092483516A5051261755 @default.
• W3092483516 hasAuthorship W3092483516A5071646305 @default.
• W3092483516 hasAuthorship W3092483516A5072952978 @default.
• W3092483516 hasAuthorship W3092483516A5073179735 @default.
• W3092483516 hasAuthorship W3092483516A5080055664 @default.
• W3092483516 hasAuthorship W3092483516A5084708084 @default.
• W3092483516 hasBestOaLocation W30924835161 @default.
• W3092483516 hasConcept C104317684 @default.
• W3092483516 hasConcept C126322002 @default.
• W3092483516 hasConcept C143998085 @default.
• W3092483516 hasConcept C174475383 @default.
• W3092483516 hasConcept C207103383 @default.
• W3092483516 hasConcept C2483381 @default.
• W3092483516 hasConcept C2777408962 @default.
• W3092483516 hasConcept C2778729363 @default.
• W3092483516 hasConcept C2911091166 @default.
• W3092483516 hasConcept C30481170 @default.
• W3092483516 hasConcept C44249647 @default.
• W3092483516 hasConcept C53226629 @default.
• W3092483516 hasConcept C55493867 @default.
• W3092483516 hasConcept C71924100 @default.
• W3092483516 hasConcept C86803240 @default.
• W3092483516 hasConcept C90924648 @default.
• W3092483516 hasConceptScore W3092483516C104317684 @default.
• W3092483516 hasConceptScore W3092483516C126322002 @default.
• W3092483516 hasConceptScore W3092483516C143998085 @default.
• W3092483516 hasConceptScore W3092483516C174475383 @default.
• W3092483516 hasConceptScore W3092483516C207103383 @default.
• W3092483516 hasConceptScore W3092483516C2483381 @default.
• W3092483516 hasConceptScore W3092483516C2777408962 @default.
• W3092483516 hasConceptScore W3092483516C2778729363 @default.
• W3092483516 hasConceptScore W3092483516C2911091166 @default.
• W3092483516 hasConceptScore W3092483516C30481170 @default.
• W3092483516 hasConceptScore W3092483516C44249647 @default.
• W3092483516 hasConceptScore W3092483516C53226629 @default.
• W3092483516 hasConceptScore W3092483516C55493867 @default.
• W3092483516 hasConceptScore W3092483516C71924100 @default.
• W3092483516 hasConceptScore W3092483516C86803240 @default.
• W3092483516 hasConceptScore W3092483516C90924648 @default.
• W3092483516 hasIssue "2" @default.
• W3092483516 hasLocation W30924835161 @default.
• W3092483516 hasOpenAccess W3092483516 @default.
• W3092483516 hasPrimaryLocation W30924835161 @default.
• W3092483516 hasRelatedWork W1900595920 @default.
• W3092483516 hasRelatedWork W1998001202 @default.
• W3092483516 hasRelatedWork W2114624491 @default.
• W3092483516 hasRelatedWork W2194631636 @default.
• W3092483516 hasRelatedWork W2972456598 @default.
• W3092483516 hasRelatedWork W3030478317 @default.
• W3092483516 hasRelatedWork W3030591904 @default.
• W3092483516 hasRelatedWork W3111094672 @default.

• next